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Abstract
Prions are pathogens with an unusually high tolerance to inactivation and constitute a complex challenge to the re-
processing of surgical instruments. On the other hand, however, they provide an informative paradigm which has been
exploited successfully for the development of novel broad-range disinfectants simultaneously active also against bacteria,
viruses and fungi. Here we report on the development of a methodological platform that further facilitates the use of
scrapie prions as model pathogens for disinfection. We used specifically adapted serial protein misfolding cyclic
amplification (PMCA) for the quantitative detection, on steel wires providing model carriers for decontamination, of 263K
scrapie seeding activity converting normal protease-sensitive into abnormal protease-resistant prion protein. Reference
steel wires carrying defined amounts of scrapie infectivity were used for assay calibration, while scrapie-contaminated test
steel wires were subjected to fifteen different procedures for disinfection that yielded scrapie titre reductions of #10
1-t o
$10
5.5-fold. As confirmed by titration in hamsters the residual scrapie infectivity on test wires could be reliably deduced for
all examined disinfection procedures, from our quantitative seeding activity assay. Furthermore, we found that scrapie
seeding activity present in 263K hamster brain homogenate or multiplied by PMCA of scrapie-contaminated steel wires
both triggered accumulation of protease-resistant prion protein and was further propagated in a novel cell assay for 263K
scrapie prions, i.e., cerebral glial cell cultures from hamsters. The findings from our PMCA- and glial cell culture assays
revealed scrapie seeding activity as a biochemically and biologically replicative principle in vitro, with the former being
quantitatively linked to prion infectivity detected on steel wires in vivo. When combined, our in vitro assays provide an
alternative to titrations of biological scrapie infectivity in animals that substantially facilitates the use of prions as potentially
highly indicative test agents in the search for novel broad-range disinfectants.
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Introduction
Prions are the causative agents of transmissible spongiform
encephalopthies (TSEs) such as scrapie in sheep and goats, bovine
spongiform encephalopathy (BSE) in cattle, chronic wasting
disease (CWD) in cervids or Creutzfeldt-Jakob disease (CJD) and
its variant form (vCJD) in humans. They are thought to consist
essentially of host-encoded prion protein (PrP) with a pathological
folding and aggregation structure, referred to as PrP
Sc [1,2] or
PrP
TSE [3]. Substantial evidence suggests that the replication of
prions is mediated by a process of seeded polymerization [4]. In
this process PrP
TSE particles (that may or may not contain further
components or obtain assistance by helper molecules) exert a
proteinaceous seeding activity by putatively acting as nuclei which
recruit cellular prion protein (PrP
C) and incorporate it, in a beta-
sheet rich amyloid form, into growing aggregates of misfolded PrP.
Fragmentation of such aggregates eventually mediates the
multiplication of PrP particles with proteinaceous seeding activity,
resulting in autocatalytic replication of the pathological protein
state. Experimentally, prion-associated seeding activity converting
normal protease-sensitive PrP into Proteinase K-resistant prion
protein (PrPres) can be monitored in vitro by protein misfolding
cyclic amplification (PMCA) [5,6].
Serial PMCA [7,8] has been established during the past few
years as a powerful tool for the ultra-sensitive - yet generally non-
quantitative - detection of minute amounts of PrP
TSE. Chen et al.
[9] and Wilham et al. [10] recently described two technical
advancements, called quantitative PMCA (qPMCA) and real-time
quaking induced conversion assay (RT-QuIC), which showed that
the estimation of prion titres and prion seeding activity,
respectively, are biochemically feasible in vitro with high sensitivity
and accuracy.
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e20384Prion infectivity can be titrated also biologically in vitro, as was
exemplified by cell culture assays for the quantitative detection of
RML prions in solution or on steel wires used as model carriers for
disinfection [11–13].
Although the exact chemical composition of prions has not yet
been completely elucidated, it is known since long that these
pathogens have a high resistance to inactivation (for review see
[14,15]) which resulted in cases of accidental and iatrogenic
transmissions of CJD [16]. With their proteinaceous nature, high
tolerance against inactivation and pronounced binding affinity to
steel surfaces [17,18] prions provide in many respects a worst case
contamination of surgical instruments and medical devices [19,20]
that constitutes both a substantial challenge and informative
paradigm for disinfection.
Indeed, prions were recently successfully exploited as model
pathogens for the development of novel broad-range disinfectants
with simultaneous activity against microbial, viral and TSE agents
[21,22]. In these reports the 263K scrapie hamster model that has
been applied for many TSE inactivation studies [14,15] was used
in conjunction with a steel wire assay mimicking the surface of
surgical instruments [17,18,23–25]. For our previous study [22]
we devised a three-stage test procedure in which candidate
formulations for broad-range disinfection were screened initially
for their ability to reduce the burden of 263K scrapie-associated
PrP
TSE on test steel wires. Formulations found to be effective on
PrP
TSE in this assay were then tested microbiologically for their
activities against bacteria, viruses and fungi, and those showing a
pronounced broad-range disinfection activity in vitro were finally
validated by titrating the decrease of prion infectivity in hamster
bioassays.
The identification of a simple yet highly effective formulation
for fast broad-range decontamination of surgical instruments from
bacteria, viruses, fungi and prions by this approach [22] provided
a proof-of-principle for the use of prions as model agents in the
search for novel broad-range disinfectants. This prompted us to
further refine the monitoring of the activity of disinfectant
formulations against prions in terms of speed, throughput, costs
and ethical considerations on the protection of animals [26].
Conceptually, prion replication by seeded polymerization would
implicate the seeding activity of PrP
TSE as the biochemical
analogue of biological prion infectivity. Thus, we examined
whether it would be possible to assess scrapie infectivity in our
steel wire assay without titrations in animals by biochemical
measurement and biological detection of 263K scrapie seeding
activity in vitro. Specifically adapted quantitative serial PMCA and
a novel glial cell culture assay were tested for this purpose.
Results
Quantitative PMCA for measuring the proteinaceous
seeding activity of 263K scrapie prions in vitro
When we developed a protocol for quantitative PMCA of prion
contaminated steel wires we took advantage of previous findings in
our laboratory indicating that the presence of glass beads in
reaction batches may substantially increase both the robustness
and sensitivity of PMCA. However, the size and amount of beads
had to be adequately adjusted for this purpose. Similar findings
were described recently by Gonzales-Montalban et al. [27].
Furthermore, as a safeguard to PMCA specificity we implemented
several different precautionary measures aiming at the prevention
of cross-contamination.
Figure 1 shows the sensitivity and specificity of the detection of
scrapie seeding activity, as well as the consistency of PrPres
amplification triggered by 263K scrapie prions, for PMCA
samples that were processed, in triplicate, according to our
modified PMCA protocol. No PrP
TSE of the seeding material was
detected by Western blotting prior to PMCA in reaction batches
containing 10
28 g/150 ml or lower concentrations of homoge-
nized 263K scrapie brain tissue. This is consistent with the
previously established sensitivity of our Western blot assay which
allows the detection of PrP
TSE in the equivalent of 2610
28 go r
higher amounts of homogenized brain tissue from terminally ill
scrapie hamsters [28]. In contrast, seeding activity could be
detected in all PMCA batches containing 10
212 g or higher
amounts of 263K scrapie brain tissue. When all safety measures
against cross-contamination had been in place unseeded samples
did not produce PrPres staining after 1, 2 or 3 rounds of PMCA
(Figure 1, bottom row).
However, we observed that the efficacy, though not the
consistency of PrPres amplification detected for identically
prepared sets of triplicate samples depended to some degree on
both the particular sonicator used for PMCA and the individual
run of sample processing at different times in the same sonicator
(not shown). This variation of protein misfolding efficacy found to
be intrinsically associated with PMCA in our hands prompted us
to perform an internal assay calibration for the quantitative
determination of scrapie seeding activity. Accordingly, unknown
samples to be tested for their seeding activity were subjected to
PMCA always together with defined reference samples and
processed in one sample set at the same time in the same sonicator.
Under the experimental conditions of our PMCA protocol, the
amount of PrPres generated after different rounds of PMCA
directly reflected the levels of seeding activity present in examined
samples. When the Western blot results shown in Figure 1 were
analysed densitometrically this confirmed a consistent quantitative
correlation between the amount of seeding material, the number
of PMCA rounds, and the staining intensity of generated PrPres
(Figure 2). In the following we used, and validated, this PMCA
protocol for the measurement of the scrapie seeding activity on
steel wires in a carrier assay for disinfection.
Quantification of proteinaceous seeding activity on
prion-contaminated steel wires in a carrier assay for
disinfection
Before addressing the quantification of proteinaceous seeding
activity on steel wires, we examined whether the presence of such
wires in reaction batches influenced the efficacy of PMCA. As
shown in Figure 3 the addition of untreated steel wires to normal
hamster brain homogenate (NBH) spiked with 10
29 or 10
210 go f
263K scrapie brain tissue had no significant impact on PrPres
amplification. Furthermore, no PrPres signals could be detected
after 1, 2, 3 or 4 PMCA rounds with unseeded NBH containing
steel wires. Hence, we observed no substantial effects of steel wires
on PMCA: Such wires did neither boost specific or unspecific
PrPres amplification nor did they cause relevant inhibitory effects
in our assay.
Next, we applied our PMCA procedure to prion-contaminated
steel wires for an assessment of scrapie seeding activities in a carrier
assay for disinfection. Test-, reference- and negative control steel
wires were included into the analysis. Scrapie-contaminated test
steel wires were subjected to various procedures for disinfection,
while reference steel wires carried defined amounts of scrapie agent
for assay calibration. Negative control steel wires were contaminat-
ed with 10
21-diluted NBH, only. Different sample sets each
containing i) test wires that had been exposed to procedures for
disinfection, ii) reference wires for assay calibration and iii) negative
control wires were assorted, and the samples belonging to one
Prions in Broad-Range Disinfection
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same sonicator, to PMCA.
Figure 4 shows the amplification of PrPres after 1, 2, 3 and 4
rounds of PMCA seeded with duplicates (S1, S2) of test-,
reference- and negative control (neg. ctrl.) steel wires that had
been contaminated with the indicated dilutions of scrapie hamster
brain homogenate (SBH) or NBH. As previously observed for
PMCA without steel wires, the efficacy of PrPres amplification
depended to some degree on the very sonicator (or the individual
run of sample set processing at different times in the same
sonicator) for sample sets 1–3. However, duplicate test- and
reference samples processed together at the same time in the same
sonicator produced consistent PrPres amplification. With negative
control wires no PrPres amplification was detected.
No PrPres could be detected after 1, 2, 3 or 4 rounds of PMCA
following exposure of test wires (that had been coated with 10
21-
diluted SBH) to a formulation of 0.2% SDS (sodium dodecylsul-
fate) and 0.3% NaOH for 10 min at 23uC, whereas reference
wires contaminated with 10
28-diluted SBH produced detectable
PrPres amplification after 3 (S1) and 4 rounds (S1 and S2) of
PMCA (Figure 4, sample set 1). This indicated that after treatment
in 0.2% SDS/0.3% NaOH for 10 min at 23uC any residual
seeding activity on these test wires (SATW[0.2% SDS/0.3%
NaOH, 10 min, 23uC]), if present at all, was lower than the
seeding activity of reference wires contaminated with 10
28-diluted
SBH (SARW[10
28]). Increasingly stronger residual seeding activ-
ities were revealed in the Western blots of Figure 4 after exposure
of test wires to 0.2% SDS/0.3% NaOH for 5 min at 23uC, 5%
SDS (pH 7.6) for 60 min at 90uC, 2% non-neutralised glutardial-
dehyde (pH 4.6) for 10 min at 23uC, or 0.25% peracetic acid for
60 min at 23uC.
All PMCA results were also analysed by densitometry. The
relative staining intensities of PrPres signals found for test- and
reference wires after 1, 2, 3 and 4 rounds of PMCA were
densitometrically determined as a percentage of the staining
intensities of PrPres reference standards and plotted as exemplified
Figure 2. Quantitative correlation between the amount of seeding 263K scrapie brain tissue, number of PMCA rounds and level of
PrPres amplification. Densitometric analysis of the Western blots shown in Figure 1. Relative staining intensities of PrPres found after 1, 2 and 3
rounds of PMCA seeded with the indicated amounts of 263K scrapie brain tissue are expressed as a percentage of the staining intensity of the
reference standard. Upper parts of symmetrical error bars are reproduced in order to indicate the variation (i. e. the range) of PrPres staining observed
for triplicate samples.
doi:10.1371/journal.pone.0020384.g002
Figure 1. Reproducibility, sensitivity and specificity of PMCA optimized for the quantitative determination of scrapie seeding
activity. Western blot detection of PrPres, the proteinase K–resistant core of misfolded PrP, after PMCA seeded with the indicated amounts of 263K
scrapie brain tissue. Samples were run in triplicates (S1–S3). Lane M, markers indicating the typical molecular mass of PrPres in the range of ,30 to
,20 kDa. Lane 0 represents 4.2 ml-aliquots from PMCA batches sampled prior to PMCA. Lane R, PrPres reference standard: PK-digested brain
homogenate from scrapie hamsters corresponding to 5610
27 g brain tissue. Lanes 1–3 represent 4.2 ml-aliquots from PMCA batches sampled after 1,
2 and 3 rounds of amplification.
doi:10.1371/journal.pone.0020384.g001
Prions in Broad-Range Disinfection
PLoS ONE | www.plosone.org 4 May 2011 | Volume 6 | Issue 5 | e20384in Figures 5 and 6 (left columns) for the Western blots of sample set
1 or samples sets 2 and 3 of Figure 4, respectively.
The densitometric analysis confirmed that any residual seeding
activity on test wires exposed to 0.2% SDS/0.3% NaOH for
10 min at 23uC was lower than the seeding activity on reference
wires coated with 10
28-diluted SBH (i. e. SATW[0.2% SDS/0.3%
NaOH, 10 min, 23uC] , SARW[10
28]; Figure 5, first panel),
while after the same treatment for 5 min the residual seeding
activity on the test wires was = SARW(10
28) (Figure 5, second
panel). After treatment in 5% SDS (pH 7.6) for 60 min at 90uC,
2% non-neutralised glutardialdehyde for 10 min at 23uC or 0.25%
peracetic acid for 60 min at 23uC the residual seeding activities on
test wires were found to be > SARW(10
26)t o, SARW(10
25)
(Figure 6, first panel), > SARW(10
23)t o, SARW(10
22) (Figure 6,
second panel) and . SARW(10
22)t o, SARW(10
21) (Figure 6,
third panel), respectively.
In addition to these treatments a further ten different
formulations or procedures with efficacies for disinfection known
to range from very high to very low were examined for their effects
on the scrapie seeding activity on test wires. For each disinfectant
Figure 3. Influence of steel wires on the efficacy of PMCA. Western blot detection of PrPres, the proteinase K–resistant core of misfolded PrP,
after PMCA seeded with the indicated amounts of 263K scrapie brain tissue and performed in the absence (2) or presence (+) of untreated steel
wires. Lane M, markers indicating the typical molecular mass of PrPres in the range of ,30 to ,20 kDa. Lane R, PrPres reference standard: PK-
digested brain homogenate from scrapie hamsters corresponding to 1610
26 g brain tissue. Numbered lanes 1–4 represent 4.2 ml-aliquots from
PMCA batches sampled after 1, 2, 3 or 4 rounds of amplification.
doi:10.1371/journal.pone.0020384.g003
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in quadruplicate and produced consistent results. The consolidat-
ed data from our seeding activity assay are summarized in Table 1.
Minor variations between quadruplicate seeding activity measure-
ments were observed for 0.2% SDS/0.3% NaOH/20% n-
propanol (10 min, 23uC), 0.5% alkaline cleaner (5 min, 55uC)
and steam sterilization (5 min, 134uC). However, these variations
were either consistent with, or even paralleled by bioassay findings
on test wires (Table 1).
In vitro assessment and bioassay validation of prion
infectivity on test wires
Test wires similarly processed for decontamination as those
examined in our seeding activity assay had been previously, or
were in this study, subjected to hamster bioassays for a biological
titration of infectivity. The results from the bioassays performed in
this study are summarized in the Supporting Information of Table
S1 and Table S2, while bioassay results from previous titrations
have been published by Lemmer et al. [29] and Beekes et al. [22]
(see footnote of Table 1). In addition, the infectivity titres of
reference steel wires identical to those coated with serially 10
21-t o
10
28-diluted SBH used in this report had been previously
determined as well [29], and could now be applied as conversion
factors for a tentative translation of the seeding activities detected
on test wires (Table 1, fifth column) into titre estimates of
biological prion infectivity (Table 1, sixth column). With this
experimental design, we were able to validate our in vitro
assessments of prion infectivity on test wires by directly comparing
estimated titres concluded from the seeding activity assay (Table 1,
sixth column) with actual infectivity levels detected in reporter
animals (Table 1, eighth column).
The seeding activity assay estimates for test wires exposed to
0.2% SDS/0.3% NaOH for 10 min at 23uC suggested a titre
reduction factor (RF) of .7 log10 units (logs; Table 1, seventh
column). Consistent with this in vitro assessment no residual
infectivity was detected by bioassay on similarly treated test wires.
The bioassay indicated for this treatment an infectivity reduction
factor of greater or equal 5.5 logs (Tab 1, ninth column). This was
the maximum reduction detectable by bioassay since the initial
load of infectivity on test wires contaminated with 10
21-diluted
SBH was 3610
5 50% lethal doses of 263K scrapie infectivity
following intracerebral implantation (LD50i.c.imp) per wire [29].
Decontamination with 0.2% SDS/0.3% NaOH for 5 min at
23uC, 5% SDS (pH 7.6) for 10 min at 90uC, 2% non-neutralised
glutardialdehyde for 10 min at 23uC or 0.25% peracetic acid for
60 min at 23uC produced residual seeding activities on test wires
that were indicative of titre reductions in the range of > 7, .4t o
= 5 logs, .1t o= 2 logs and .0t o,1 log, respectively.
Figure 4. Effect of disinfectants on the proteinaceous seeding activity of prion-contaminated steel wires. Western blot detection of
PrPres, the proteinase K–resistant core of misfolded PrP, after PMCA seeded with duplicate samples (S1, S2) of test-, reference- and negative control
(neg. ctrl.) steel wires that had been contaminated with the indicated dilutions of 263K scrapie- or normal hamster brain homogenate (SBH, NBH).
Test wires were exposed to the specified formulations or procedures for disinfection and subsequently subjected to PMCA together with reference
and control wires (Note: 2% glutardialdehyde was not neutralized). Results from three independently processed PMCA sample sets are shown. Each
sample set consisted of i) test wires that had been exposed to procedures for disinfection (Set 1: 0.2% SDS/0.3% NaOH applied for 10 min or 5 min at
23uC; Set 2: 5% SDS applied for 60 min at 90uC; Set 3: 2% glutardialdehyde applied for 10 min at 23uC and 0.25% peracetic acid applied for 60 min at
23uC), ii) reference wires contaminated with 10
25-t o1 0
28-diluted SBH (Sets 1 and 2) or 10
21-t o1 0
24-diluted SBH (Set 3) for assay calibration in the
range of the residual seeding activity on test wires, and iii) negative control wires contaminated with 10
21-diluted NBH (Sets 1, 2 and 3). The test-,
reference- and negative control wire samples belonging to one sample set were subjected together, i. e. at the same time and in the same sonicator,
to PMCA. Lane M, molecular mass marker; the prominent band (indicated by bars in the first column of blots) corresponds to 30 kDa. Lane R, PrPres
reference standard: PK-digested brain homogenate from scrapie hamsters corresponding to 1610
26 g brain tissue. Numbered lanes 1–4 represent
4.2 ml-aliquots from PMCA batches sampled after 1, 2, 3 or 4 rounds of amplification. Lane ‘‘Dil.’’, dilution of 263K SBH (in 10% NBH) or NBH (in buffer)
with which wires had been contaminated prior to PMCA.
doi:10.1371/journal.pone.0020384.g004
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formulations for disinfection that yielded estimated reductions of
263K scrapie titres on wires ranging from smaller than 1 log to
$5.5 logs. We found that the residual infectivities and titre
reduction factors on processed test wires suggested by the seeding
activity assay consistently matched the findings from bioassays.
Glial cell culture assay for scrapie seeding activity
In order to qualitatively test, and verify, PrP seeding as a
biologically active and replicative principle without experiments in
animals, we established a cell culture assay using cerebral glial cells
from hamsters. Examination by light microscopy and immunocy-
tochemistry revealed that our cerebral glial cell cultures contained
Figure 5. Quantification of residual proteinaceous seeding activities on prion-contaminated steel wires after exposure to a mixture
of 0.2% SDS and 0.3% NaOH. (Left panel) Densitometric analysis of PrPres amplification detected for test- and reference wires in sample set 1 of
Figure 4. The horizontal axis of plots represents reference wires contaminated with the indicated dilutions of SBH (left to axis break), or test wires
exposed to 0.2% SDS/0.3% NaOH for the indicated reaction times (right to axis break). The vertical axis of plots indicates the relative staining
intensities of PrPres signals found for reference or test wires after 1, 2, 3 and 4 rounds of PMCA expressed as a percentage of the staining intensity of
the reference standard (i. e. PK-digested brain homogenate from scrapie hamsters corresponding to 1610
26 g brain tissue). The color coding of bars
representing the first, second, third and fourth round of PMCA is defined in the column ‘‘PMCA-Round’’ of the right panel. Upper parts of symmetrical
error bars are reproduced in order to indicate the variation (i. e. the range) of results for duplicate reference samples and individual test samples after
three independently performed densitometric measurements of Western blot signals. (Right panel) Classification of residual seeding activities of test
wires in relation to the seeding activities of reference wires for 1, 2, 3 and 4 rounds of PMCA, and deduction of consolidated values of residual seeding
activities on test wires (assessments refer to the reaction times of 0.2% SDS/0.3% NaOH specified in the plots on the left hand side). Explanation of
abbreviations: SATW[Max.],S A TW[Mean],S A TW[Min.] and SATW[Cons.]; maximum-, mean-, minimum and consolidated values of the seeding actvity of test
wires. N.a., no assessment. SARW(10
25)-S A RW(10
28) designate seeding activities of reference wires contaminated with 10
25-t o1 0
28-diluted SBH.
doi:10.1371/journal.pone.0020384.g005
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appearance and by immunolabelling of glial fibrillary acidic
protein, not shown) as well as other non-neuronal cells (that were
not specifically immunolabelled but morphologically resembled
oligodendrocytes and microglia, not shown). The level of PrP
C
expression regularly found in our glial cell cultures at 40 days post
initial exposure (DPE) to NBH, i. e. at a time point when cells were
usually harvested for the analysis of PrPres accumulation after
challenge with 263K scrapie brain homogenate, is shown in Figure
S1 of the Supporting Information. Similar levels of PrP
C
expression were also found at 60 DPE (not shown). Using these
cell cultures for assaying 263K scrapie seeding activity the
following results were obtained in experiments carried out in
duplicate or a higher number of independent runs.
We found that our cultures of cerebral glial cells isolated from
newborn Syrian hamsters showed a consistent accumulation of
Table 1. Seeding activity assay and bioassay of test steel wires used as model carriers for prion disinfection.
Seeding activity assay of test wires Bioassay of test wires
Formulation/ Concen- Time Tempera-
Residual seeding
activity on test wires
Estimated residual
infectivity Estimated
Residual
infectivity Reduction of
Procedure tration [min] ture [6C]
(as compared to
the seeding activity per wire
reduction
of per wire infectivity
on reference wires) [LD50i.c.imp]
infectivity
[logs] [LD50i.c.imp] [logs]
#
Sodium hydroxide 1.0 M 60 23 , SARW(10
28) ,3610
22 .7U D
{ $5.5
{
Sodium hypochlorite 2.5% 60 23 = SARW(10
28) =3610
22 > 7U D
{ $5.5
{
GdnSCN 4.0 M 10 23 = SARW(10
28) =3610
22 > 7U D
" $5.5
"
SDS/NaOH 0.2%/0.3% 10 23 , SARW(10
28) ,3610
22 .7U D
{ $5.5
{
52 3 = SARW(10
28) =3610
22 > 7U D
{ $5.5
{
SDS/NaOH/ 0.2%/0.3% 10 23 = SARW(10
28) =3610
22 > 7U D
{ $5.5
{
n-Propanol 20% . SARW(10
28)t o= SARW(10
27) .3610
22 to =3610
21 .6t o= 7
Alkaline cleaner 1.0% 60 23 , SARW(10
28) ,3610
22 .7U D
{ $5.5
{
0.5% 10 55 . SARW(10
27)t o= SARW(10
26) .3610
21 to =3610
0 > 5t o,6 .0t o#3610
0{ $5t o#5.5
{
0.5% 5 55 . SARW(10
27)t o= SARW(10
26) .3610
21 to =3610
0 > 5t o,6 .0t o#3610
0{ $5t o#5.5
{
. SARW(10
26)t o= SARW(10
25) .3610
0 to =3610
1 > 4t o,5 .3610
0 to
#3610
1{
$4t o,5
{
Steam sterilization 5 134 < SARW(10
26) <3610
0 < 5 .0t o,3610
0{ .5t o,5.5
{
> SARW(10
26)t o, SARW(10
25) >3610
0 to ,3610
1 .4t o= 5
SDS (pH 7.6) 5% 60 90 > SARW(10
26)t o, SARW(10
25) >3610
0 to ,3610
1 .4t o= 5 .3610
0 to
#3610
1{
$4t o,5
{
Glutardialdehyde 2% 10 23 . SARW(10
24)t o= SARW(10
23) .3610
2 to =3610
3 >2t o,3 <3610
3" < 2
"
(neutral., pH 7.0)
Glutardialdehyde 2% 10 23 > SARW(10
23)t o, SARW(10
22) >3610
3 to ,3610
4 .1t o= 2 .3610
3 to
,3610
4"
.1t o,2
"
non-neutral., pH 4.6)
Cidex OPA 0.55% 10 23 . SARW(10
23)t o, SARW(10
22) .3610
3 to ,3610
4 .1t o,2 .3610
3 to
,3610
4"
.1t o,2
"
Peracetic Acid 0.25% 60 23 . SARW(10
22)t o, SARW(10
21) .3610
4 to ,3610
5 .0t o,1 .3610
4 to
#3610
5{
$0t o,1
{
Test wires contaminated with 10
21-diluted 263K scrapie brain homogenate carried an initial infectivity load of approximately 3610
5 LD50i.c.imp/wire, and reference wires
contaminated with 10
21-, 10
22-, 10
23-, 10
24,1 0
25-, 10
26,1 0
27- and 10
28-diluted 263K scrapie brain homogenate carried 3610
5-, 3610
4-, 3610
3-, 3610
2-, 3610
1-,
3610
0-, 3610
21-o r3 610
22 LD50i.c.imp/wire, respectively [29]. Reduction of prion infectivity on test wires is expressed in log10 units (logs). Explanation of abbreviations:
neutrl. – neutralized; UD - undetectable. Explanation of symbols:
#Test limit of bioassay for titre reduction: 5.5 logs [29];
{, {Previously published bioassay results ([29]
{[22]
{).
"Bioassay results from this work (see Table S1 and Table S2).
doi:10.1371/journal.pone.0020384.t001
Figure 6. Quantification of residual proteinaceous seeding activities on prion-contaminated steel wires after exposure to SDS,
glutardialdehyde or peracetic acid. (Left panel) Densitometric analysis of PrPres amplification detected for test- and reference wires in sample
sets 2 and 3 of Figure 4. The horizontal axis of plots represents reference wires contaminated with the indicated dilutions of SBH (left to axis break), or
test wires exposed to the specified disinfectant (right to axis break). Vertical axis, color coding of bars and error bars as described for Figure 5. (Right
panel) Classification of residual seeding activities on test wires exposed to the disinfectants specified in the plots on the left hand side (the analyses
were performed similarly to Figure 5). Abbreviations: As in Figure 5, with SARW(10
21)-S A RW(10
28) designating seeding activities of reference wires
contaminated with 10
21-t o1 0
28-diluted SBH.
doi:10.1371/journal.pone.0020384.g006
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cells had been adequately dispersed and adjusted to an optimized
concentration before inoculation. The cultures were exposed for 3
days to NBH spiked with 2.5610
25 g of scrapie brain tissue,
washed, and incubated until 40 DPE. Western blotting of cells
harvested at different time-points after inoculation revealed
increased levels of PrPres at 31 and 40 DPE as compared to the
PrPres staining found at 3 DPE (which probably originated from
residual inoculum that could not be washed off the cells; Figure 7,
blot in the middle). PrPres accumulation was also observed at 40
DPE after exposure of cells to inoculum that contained 1610
26 go f
scrapie brain tissue per culture (Figure 7, blot on the right-hand
side), but not consistently when cultures were exposed to 1610
27 g
of scrapie brain tissue (not shown). No PrPres could be detected at 3
or 40 DPE in extracts from glial cell cultures similarly exposed to
NBH only (Figure 7, blot on the left hand side).
Next, we exposed glial cell cultures for 3 days to PMCA
products seeded by reference steel wires coated with 10
28-diluted
SBH, or by test steel wires exposed to different disinfectant
formulations. As shown in Figure 8 the PMCA product seeded by
reference steel wires, and the PMCA products seeded by test steel
wires that had been treated in 4 M GdnSCN (10 min, 23uC) or
5% SDS (pH 7.6, 60 min, 90uC), triggered PrPres accumulation
in the glial cell cultures (Figure 8, second, fourth and fifth blot
from the left hand side). This was not observed with PMCA
products derived from test steel wires exposed to 1 M NaOH
(60 min, 23uC; Figure 8, third blot from the left hand side). Also,
control samples from similar PMCA reactions that were mock-
seeded by steel wires contaminated with 10
21-diluted NBH did
not produce detectable PrPres signals in glial cell cultures at 3, 40
or 60 DPE (Figure 8, first blot from the left hand side). The
molecular identity of accumulated PrPres in glial cell cultures was
confirmed by using an alternative antibody for PrPres labelling
(i. e. anti-PrP antibody ICSM-18 [D-Gen, UK] instead of anti-PrP
antibody 3F4), as well as by enzymatic deglycosylation [28].
Western blotting with the antibody ICSM-18 revealed bands in
the molecular mass range of diglycosylated, monoglycosylated and
occasionally ungycosylated PrPres (not shown). Furthermore, after
treatment with N-glycosidase F (PNGase F) and Western blot
staining with the antibody 3F4 the putative PrP bands shown in
Figure 7 displayed a uniform shift to approximately 19 kDa, the
molecular mass expected for the unglycosylated form of hamster
PrPres (not shown). These findings confirmed the identity of the
immunolabelled material in our glial cell cultures as PrPres.
The preparation of primary hamster glial cell cultures and their
inoculation with 263K scrapie brain homogenate or PMCA
products has been carried out, partly by different operators, in our
laboratory in more than 20 independently performed experiments
so far. Glial cell cultures consistently accumulated in replicate tests
PrPres after exposure to these inocula as exemplified in Figures 7
and 8, indicating that they constantly provided the same quality
for prion susceptibility.
Furthermore, we validated the biological propagation of PrP
seeding in our cell culture assay by testing whether the newly
formed PrPres, again, is associated with proteinaceous seeding
activity in PMCA. Lysates from glial cell cultures inoculated with
10
26 g of homogenized 263K scrapie brain tissue in NBH, or with
a PrPres-positive PMCA product derived from test steel wires that
had been exposed to 4 M GdnSCN (10 min, 23uC), showed both
accumulation of PrPres (Figure 7, blot on the right hand side;
Figure 8, fourth blot from the left hand side) and increased seeding
activity (Figure 9, first and third row) at 40 DPE as compared to 3
DPE. In contrast, PrPres-negative lysates from glial cell cultures
exposed to inocula not containing detectable amounts of PrPres
Figure 7. PrPres-accumulation in glial cell cultures exposed to scrapie brain homogenate. Western blot detection of PrPres, the
proteinase K–resistant core of misfolded PrP, at the indicated days post initial exposure (DPE) in glial cell cultures from hamsters inoculated with NBH
containing 0, 2.5610
25, or 1.0610
26 g 263 K scrapie brain tissue. Lanes DPE represent 3.8 ml-aliquots from resuspended cell culture pellets harvested
at the indicated days post initial exposure. Lane M, molecular mass marker; the prominent band (indicated by bar) corresponds to 30 kDa. Lane R,
PrPres reference standard: PK-digested brain homogenate from scrapie hamsters corresponding to 5610
27 g brain tissue.
doi:10.1371/journal.pone.0020384.g007
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product derived from test steel wires treated in 1 M NaOH for
60 min at 23uC [Figure 8, third blot from the left hand side] did
not show any detectable seeding activity in PMCA (Figure 9,
second and fourth row of blots).
Thus, scrapie brain tissue as well as PMCA products derived
from seeds such as prion contaminated steel wires specifically
triggered both accumulation of PK-resistant PrP and amplification
of proteinaceous seeding activity in our cell assay. This provided a
direct in vitro demonstration of PrP seeding as a biologically active
and replicative principle, since PrP seeding had been transmitted
to and propagated by our glial cell cultures.
Discussion
Prions have a particularly high tolerance to inactivation [14,15].
Therefore, they constitute a complex challenge to the safe
maintenance of re-usable surgical instruments and medical devices
[30]. However, as recently shown, this challenge can be turned
into benefit when prions are exploited as an informative paradigm
for the development of novel disinfectants that are simultaneously
active against bacteria, viruses as well as fungi [21,22]. In order to
further facilitate the use of prions as model agents in the search for
novel broad-range disinfectants we established an experimental
platform for the sensitive quantitative measurement and biological
detection of scrapie seeding activity in vitro.
In our study scrapie seeding activity on prion-contaminated
steel wires processed for decontamination was quantified by
specifically adapted PMCA. PMCA has been used previously by
other groups as a rapid test for the assessment of prion inactivation
[31,32], however, not in a quantitative way. PMCA needs to be
highly standardized and robust in terms of a consistent and
objectively quantifiable PrPres amplification if to be used for a
quantification of the proteinaceous seeding activity of prions. Only
recently it was reported that conducting PMCA in the presence of
Teflon beads significantly improves the yield, rate and robustness
of PrP conversion seeded by 263K scrapie prions [27]. When we
developed our protocol for quantitative PMCA we observed a
similar effect after the addition of glass beads, but not after the
addition of steel wires to PMCA reaction batches. Although the
exact mechanistic explanation has not yet been established for
these phenomena they suggest the number, material and/or form
of solid bodies in PMCA batches as factors that may influence the
efficacy of PrPres amplification. Consistent with this conclusion
Gonzales-Montalban and colleagues [27] reported that the
diameter of Teflon beads was of critical importance for the bead
effect on PMCA.
From the results of our quantitative seeding activity assay we
were able to correctly estimate, as validated by titrations in
hamsters, the residual infectivity on test wires subjected to 15
different procedures or formulations exerting various mechanisms
of action for prion disinfection. Reductions of scrapie titres ranged
Figure 8. PrPres-accumulation in glial cell cultures exposed to PMCA products. Western blot detection of PrPres at the indicated DPE in
glial cell cultures from hamsters inoculated with PMCA products seeded by control-, reference and test steel wires of the carrier assay for disinfection
and harvested after the 4
th round of amplification. Negative control (neg. ctrl) wires, reference wires and test wires had been contaminated with
10
21-diluted (dil.) NBH, 10
28-diluted SBH and 10
21-diluted SBH, respectively, and test wires were subjected to the indicated disinfection procedures
prior to PMCA. PMCA products from negative control wires and test wires exposed to 1M NaOH were PrPres-negative (
{, see Figure 3 for negative
control wires [set 1, S1, 4
th round]; otherwise not shown), while PMCA products from reference wires and test wires exposed to 4M GdnSCN or 5%
SDS were positive for PrPres (
{, see Figure 3 for reference wires [set 2, S1, 4
th round] or for test wires incubated in 5% SDS [set 2, S2, 4
th round];
otherwise not shown). Lanes DPE represent 3.8 ml-aliquots from resuspended cell culture pellets harvested at the indicated days post initial exposure.
Lane M, molecular mass marker; the prominent band (indicated by bar) corresponds to 30 kDa. Lane R, PrPres reference standard: PK-digested brain
homogenate from scrapie hamsters corresponding to 5610
27 g brain tissue.
doi:10.1371/journal.pone.0020384.g008
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PLoS ONE | www.plosone.org 11 May 2011 | Volume 6 | Issue 5 | e20384Figure 9. Propagation of seeding activity in glial cell cultures exposed to scrapie brain homogenate or PMCA products. Western blot
detection of PrPres, the proteinase K–resistant core of misfolded PrP, after PMCA seeded with lysate extracts from hamster glial cell cultures that had
been harvested at 3 or 40 days post initial exposure (DPE) to 263K scrapie brain tissue, normal hamster brain homogenate (NBH), or PMCA products
derived from test steel wires treated with 4M GdnSCN (10 min, 23uC) or 1 M NaOH (60 min, 23uC) in the carrier assay for disinfection. Note: Lysate
extracts from 3- and 40 DPE glial cell cultures exposed to the PMCA product from test steel wires treated with 4M GdnSCN (10 min, 23uC) were
diluted 1:25 for PMCA seeding in this experiment. Lane M, markers indicating the typical molecular mass of PrPres in the range of ,30 to ,20 kDa.
Lane R, PrPres reference standard: PK-digested brain homogenate from scrapie hamsters corresponding to 5610
27 g brain tissue. Numbered lanes 1–
3 represent 4.2 ml-aliquots from PMCA batches sampled after 1, 2 and 3 rounds of amplification.
doi:10.1371/journal.pone.0020384.g009
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5.5-fold. In our PMCA assay we found
a consistent quantitative correspondence between the biochemical
seeding activity and biological infectivity of 263K scrapie prions.
Additionally to this quantitative correlation we showed that PrP
seeding activity present in scrapie brain homogenate or multiplied
by PMCA could be transmitted to and propagated in the
biological system of cerebral glial cell cultures from hamsters.
Thus, PrP seeding was demonstrated in our experimental setup to
represent both a biochemically and biologically active and
replicative principle in vitro.
The results of our study have different methodological,
conceptual and practical implications. Firstly, they show that
PrP seeding activities can be quantitatively detected, and
translated into scrapie infectivity titres, on steel wires used as
model carriers for disinfection by an in vitro method that
supplements the recently published approaches of qPMCA [9]
and RT-QuIC [10]. However, other than qPMCA and RT-Quic
our seeding activity assay is based on an internal calibration. Our
test samples were subjected to PMCA always together with defined
reference samples and processed in one sample set in the same
sonicator. Yet, we occasionally observed differences in the Western
blot staining intensities of similar PrPres reference standards that
were independently blotted. Such inter-blot variation can be seen
in Figure 4 when the signals in lanes R on the reference wires blots
in sample sets 1 and 2 are compared to those in sample set 3. We
noted that such variations occurred when different preparations of
Western blot reagents were used, and it cannot be ruled out that
blocking reagents, components of the chemoluminescence kit,
PrPres reference standards and molecular mass standards for
sample sets 1 and 2 on the one hand, and for sample set 3 on the
other hand, were taken from different preparations. Although we
intended to minimize such variations they could not be completely
avoided due to the need for a regular renewal of depleted reagent
stocks. Against this background, we did quantitatively compare
Western blots only within internally calibrated sets of samples that
had been processed together for PMCA and Western blotting
(using the same preparations of blotting reagents), but not between
independently processed sample sets. When doing so, neither
variations in the efficacy of protein misfolding amplification (such
as occasionally observed between sample sets processed in different
sonicators, or between sample sets processed at differerent times in
the same sonicator), or of Western blotting, nor subtle differences
in the PrPres contents of different preparations of PrPres reference
standards were found to bias the results of our seeding activity
assay.
Consistent with the quantitative correlation between scrapie
seeding activity and prion infectivity observed in our study,
Wilham et al. [10] recently reported results that also pointed to a
direct quantitative correspondence between the seeding and
infectious activities of 263K scrapie prions measured by RT-
QuIC and bioassay. This provides a remarkable concurrence
given the methodological differences of the two studies, and seems
to further substantiate the association between these prion-
associated activities.
Secondly, we were able to establish a cell culture assay, using
cerebral glial cells from hamsters, that showed accumulation of
PrPres and amplification of proteinaceous seeding activity upon
challenge with 263K scrapie brain homogenate or PMCA
products derived from this prion strain. Wang et al. [33] recently
reported the induction of PrPres accumulation in cultures of SN56
cells that had been exposed to recombinant murine PrPres
produced by PMCA. In our study we show that glial cell cultures
were not only susceptible to PrP seeding activity in terms of
inducing PrPres accumulation but also capable of propagating
seeding activity as evidenced by PMCA. This demonstrates scrapie
seeding activity as a biologically active and replicative principle in
vitro. So far, infection of cultivated cells with 263K scrapie prions
was reported only in one publication [34]. Thus, our cell culture
assay may provide a helpful novel tool in different areas of TSE
research working with the frequently used 263K scrapie agent.
Specifically, neither cell cultures susceptible to 263K scrapie-
derived PMCA products, nor the direct demonstration, by PMCA,
of the replication of prion seeding activity in cell cultures have
been described, yet. Multiplied scrapie seeding activity derived by
PMCA from 263K scrapie prions had been previously demon-
strated to be associated with replicated infectivity in vivo [35,36].
However, formally, such association cannot be taken for granted
under experimental conditions other than exactly those examined
in these (or similar) reports. For obvious reasons (e. g. ethical
considerations or costs) the association between PrP seeding
activity and prion infectivity can be validated only exemplarily in
animals. In contrast, our cell culture assay may provide a
practicable standard for the routine validation in vitro of PMCA-
detected scrapie seeding activity as a biologically active and
replicative principle.
Thirdly, when biochemical assays for the quantification of prion
seeding activity are accompanied by a demonstration of the latter’s
propagation also in a biological system such as glial cell cultures,
this seems to quantitatively and qualitatively mimic the in vivo
detection of prion infectivity as exemplified in our experimental
setup. Such approach may thus provide an effective or even
superior alternative to bioassays in animals for various research
purposes. Cell culture-coupled PMCA is faster, cheaper and
ethically less critical than in vivo titrations of prion infectivity. In
addition, it has a higher sensitivity and allows testing with a larger
throughput. While the test limit of bioassays for the reduction of
scrapie titres on steel wires was found to be about 5.5 logs in our
[29] or other in vivo carrier assays for disinfection [21,23,25], at
least 7 logs of seeding activity reduction can be monitored by
PMCA testing of steel wires. Therefore, our in vitro approach may
better resolve the safety margins of different prion disinfectants
found to completely abolish detectable infectivity in bioassays. It
may also scale the efficacy of disinfectants with higher differen-
tiation than bioassays in hamsters, provided that reference wires
contaminated with serially 2- or 5-fold- (instead of 10-fold-) diluted
SBH were used for calibration.
Fourthly, in our experimental setup, we have shown that PrP
seeding represents both a biochemically and biologically replicat-
ing and active principle in vitro, and that the former is
quantitatively linked to prion infectivity titrated on steel wires in
vivo. This would be compatible with PrP seeding and prion
infectivity as corresponding manifestations of the same replicative
activity as implicated by the nucleation-polymerization model [4]
of prion replication.
However, with respect to the latter two points, additional studies
are necessary to further substantiate the observed association
between the seeding activity and biological infectivity of 263K
prions for other disinfectant formulations and modes of inactiva-
tion. In addition, the methodological, conceptual and practical
results described in this report for 263K scrapie prions should be
validated for the most relevant human TSE agents [37,38] (such as
prions associated with sporadic CJD [sCJD]/subtypes MM1 or
VV2 [39], or variant CJD) on different types of carriers or surfaces
[40]. For this purpose, PMCA protocols and cell culture protocols
need to be adapted for the propagation and detection of PrP
seeding activities associated with sCJD or vCJD prions.
Finally, the findings obtained from our recent [22] and present
work suggest that the development of broad-range disinfectants
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pathogens for disinfection in the following four-stage procedure:
Stage 1) Novel candidate formulations or procedures will be tested
first in in vitro-assays that gauge the reduction of PrP
TSE as a static
biochemical marker of prion infectivity. Stage 2) In a subsequent in
vitro assay the decrease of PrP seeding activity will be measured as
a dynamic marker for prion infectivity, and the reduction of prion
infectivity will be estimated. The biological activity of PrP seeding
assayed by PMCA may be validated in a complementary cell
culture assay. Stage 3) Formulations or procedures found to be
effective on prions in the screening at stages 1 & 2 are further
tested in microbiological assays for their activities against bacteria,
viruses and fungi. Stage 4) Formulations and procedures that
successfully passed these in vitro tests shall be ultimately validated
for the reduction of prion infectivity by in vivo assaying in animals.
Advantageously, all tests of this staged procedure can be
performed in solution or on test carriers, and with a largely
reduced need for experiments in animals.
Materials and Methods
Ethics Statement
All animal work performed in this study was conducted under
the European directive regarding the protection of animals used
for experimental and other scientific purposes in strict accordance
with the German Animal Welfare Act (Tierschutzgesetz) and
adhering to the guidelines for the practical implementation of the
German Animal Welfare Act published by the Charite ´–
University Medicine Berlin (a joint institution of the Free
University of Berlin and the Humboldt-University of Berlin,
Germany). The protocol was reviewed and approved by the
responsible Committee on the Ethics of Animal Experiments
(‘‘Tierversuchskommission – Berlin’’) affiliated at the Authority for
Animal Protection in Berlin (‘‘Landesamt fu ¨r Gesundheit und
Soziales Berlin’’, Berlin, Germany; http://www.lageso.berlin.de;
Permit Number G0203/03). All surgery was performed under
Ketavet/Rompun anesthesia, and all efforts were made to
minimize suffering. According to German regulations, the sacrifice
of normal Syrian hamsters for experimental purposes such as
pursued in our study did not require approval by ethics
committees or animal protection authorities. However, we
voluntarily reported euthanasia of normal Syrian hamsters for
the removal of brain tissue to the animal protection authority
which registered this notification (Landesamt fu ¨r Gesundheit und
Soziales Berlin, Berlin, Germany; Registration Number T0220/
07).
Contamination, processing and seeding activity analysis
of stainless steel wires used as model carriers for prion
disinfection
The contamination and processing of stainless steel wires used
as model carriers for disinfection was performed as described
elsewhere [19] with modifications. In brief: Stainless steel wire
(DIN-No. 1.4301, Forestadent, Pforzheim, Germany; diameter
0.25 mm) was cut into 5 mm long pieces. The resulting test bodies
(here called wires) had a surface of ,4.0 mm
2, were washed in 2%
Triton X-100 for 15 min under constant sonication (Sonorex RK
102 P; Bandelin Electronics), rinsed in distilled water, dried and
sterilized in a steam autoclave at 121uC for 20 min. For
contamination with scrapie prions, batches of 15 test steel wires
were incubated in 150 ml of 10
21-diluted 263K scrapie hamster
brain homogenate (SBH, containing 0.1 g of brain tissue per 1 ml)
for 2 h under constant shaking at 37uC and 700 revolutions per
minute (rpm) in a thermomixer (Amersham Biosciences). Batches
of 15 reference steel wires each were similarly contaminated with
10
21-, 10
22-, 10
23-, 10
24-, 10
25-, 10
26-, 10
27- and 10
28-diluted
SBH, and batches of 15 negative control steel wires were
contaminated by incubation in 150 ml of 10
21-diluted normal
hamster brain homogenate (NBH). 10
21-dilutions of SBH and
NBH were prepared in Tris-buffered saline (TBS: 10 mM Tris-
HCl, 133 mM NaCl, pH 7.4). However, lower concentrated SBH
was prepared by dilution in 10% (w/v) NBH in order to warrant a
comparable load of biological contamination with normal hamster
brain tissue on test-, reference- and negative control steel wires.
Following removal of the scrapie- or normal hamster brain
homogenates, wires were transferred to and placed separately from
each other in Petri dishes, air-dried for 1 h, and stored overnight
(,16 h) at room temperature. Dried reference and control steel
wires were recollected in 0.5 ml Eppendorf safe lock tubes.
Batches of 15 contaminated test steel wires were exposed to the
following formulations or procedures for prion disinfection:
(a) 1.0 M sodium hydroxide (NaOH, 60 min, 23uC); (b) 2.5%
(w/v) sodium hypochlorite (NaOCl, .20 000 ppm available
chlorine, 60 min, 23uC); (c) 4.0 M guanidine thiocyanate
(GdnSCN, 10 min, 23uC); (d, e) a mixture of 0.2% (w/v) SDS
and 0.3% (w/v) sodium hydroxide (in the following referred to as
0.2% SDS/0.3% NaOH) applied for 5 min (d) or 10 min (e) at
23uC; (f) 0.2% SDS/0.3% NaOH in 20% (v/v) n-propanol
(10 min, 23uC); (g–i) an alkaline cleaner for medical devices [41] at
concentrations of 1.0% (v/v) applied for 60 min at 23uC (g) or
0.5% (v/v) applied for 5 min (h) or 10 min (i) at 55uC; (j) 5% (w/v)
sodium dodecylsulfate (SDS, 60 min, 90uC); (k) 2% (v/v)
glutardialdehyde (adjusted to a neutral pH of 7.0 with 0.1 M
phosphate buffer, 10 min, 23uC); (l) 2% (v/v) glutardialdehyde
(non buffered, pH 4.6), 10 min, 23uC); (m) Cidex OPA (containing
0.55% (v/v) ortho-phthalaldehyde, 10 min, 23uC); (n) 0.25% (v/v)
peracetic acid (60 min, 23uC; (o) porous load steam sterilization at
134uC and 3 bar for 5 min (performed on wires sealed in
sterilization foil).
Test wires were incubated in 1.5 ml of the disinfectant
formulations in a thermomixer (400 rpm) at the temperatures
and for the times specified above, or subjected to steam
sterilization at 134uC. Finally, all test wire batches were rinsed
under constant shaking five times, each time in 45 ml distilled
water for 10 min at room temperature. After rinsing in distilled
water, processing of test wires was finished by air-drying in Petri
dishes for 1 h, storing overnight (,16 h) at room temperature, and
recollection of batches in 0.5 ml Eppendorf safe lock tubes.
The scrapie seeding activities of test-, reference- and negative
control steel wires were quantitatively assessed per batch by
PMCA and densitometric Western blotting.
Protein misfolding cyclic amplification
The PMCA procedure described in the following was
established based on previously published protocols
[5,7,8,31,36,42,43] with 263K scrapie brain homogenate as
seeding material, and subsequently applied to test-, reference-
and negative control steel wires of the carrier assay for prion
disinfection.
Preparation of amplification substrate. Adult normal
Syrian hamsters were euthanized by exposure to CO2 and
transcardially perfused with 5 mM EDTA/phosphate buffered
saline (PBS, 8 mM Na2HPO4, 1.5 mM KH2PO4, 137 mM NaCl,
2.7 mM KCl, pH 7.4). Hamster brains were removed and
homogenized in ice-cold conversion buffer (PBS containing
complete protease inhibitor cocktail [Roche], 4 mM EDTA and
1% Triton-X-100). The homogenate was adjusted to a
concentration of 1 g brain tissue per 10 ml (i. e. to a 10
21-
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Heraeus Varifuge 3.0 at 3000 rpm and 4uC for 5 min. The
clarified supernatant was collected and stored as NBH-PMCA
substrate in aliquots at 270uC until use.
Amplification of PrP misfolding. In order to prevent cross-
contamination of samples during PMCA all pipetting steps were
performed with stuffed single-use pipette tips, and gloves were
changed each time before handling a new sample. Serial PMCA
was performed in 0.5 ml Eppendorf safe lock tubes that had been
subjected to steam sterilization at 121uC and 3 bar for 20 min
prior to use. Approximately 30 ml of glass beads (diameter 0.5–
0.75 mm; Roth, Germany) were filled into each reaction tube.
The glass beads had been both washed five times with distilled
water and subsequently subjected to steam sterilization at 121uC
and 3 bar for 20 min. Using reaction tubes prepared in this way
we performed four sets of PMCA experiments:
(i) 10 ml-aliquots of 10
21-diluted NBH containing 10
28,1 0
29,
10
210,1 0
11,1 0
212 or 0 g of homogenized 263K scrapie brain
tissue were mixed in the reaction tubes with 140 ml of NBH-
PMCA substrate for PMCA experiments without steel wires. (ii)
Similar mixtures containing 10
29,1 0
210 or 0 g of homogenized
263K scrapie brain tissue in NBH-PMCA substrate were used for
PMCA in the presence, in each PMCA round, of 15 steel wires, or
without steel wires, in order to test the influence of steel wires on
the efficacy of PMCA. (iii) For PMCA experiments with test-,
reference- and negative control steel wires of the carrier assay for
prion disinfection batches of 15 wires each were added to 150 mlo f
NBH-PMCA substrate. (iv) Finally, 5 and 10 ml aliquots of extracts
from hamster glial cell cultures were subjected to PMCA in 145 ml
and 140 ml NBH-PMCA substrate, respectively, for validating cell-
mediated propagation of scrapie seeding activity.
The reaction tubes from all sets of experiments were sealed with
parafilm and paraffin wax, and disinfected in 0.2% SDS/0.3%
NaOH for 5 min [29] after sealing. Serial PMCA was carried out
using an automatic ultrasonification apparatus (Sonicator
3000MPD or Sonicator 4000MPX from Misonix, New York,
USA). One round of PMCA consisted of 24 alternating cycles of
ultrasonification (180–190 W for 40 sec every 60 min) and
incubation of samples at 37uC between ultrasonifications. The
reaction vials were placed in 4 M GdnSCN solution [44] above
the ultrasonic transducer, and after completion of a PMCA round
the sealed reaction tubes were disinfected once more in 0.2%
SDS/0.3% NaOH for 5 min. Subsequently, reaction mixtures
were gently spun down and collected by vial puncture using
disposable hydrodermic 20 gauge needles. From the harvested
reaction mixtures 30 ml aliquots were mixed with 120 ml of fresh
NBH-PMCA substrate in new safe lock tubes containing glass
beads. For the next round of PMCA the vials were sealed and
disinfected again as described above.
Sets of PMCA experiments without steel wires (i and iv) comprised
three rounds of amplification, while those with steel wires (ii and iii)
comprised four rounds. 30 ml aliquots from PMCA-batches collected
prior to PMCA or obtained after 1, 2, 3 or 4 rounds of PMCA were
mixed with 3 ml1 3 %( w / v )s a r c o s y l ,0 . 6ml4 %( w / v )S D Sa n d6mlo f
Proteinase K stock solution (1 mg PK/ml; final concentration of PK
in digest samples: 150 mg/ml), incubated for 1 h at 55uC, and
centrifuged at 13.000 rpm and ambient temperature for 1 min
(Heraeus Biofuge pico). 30 ml aliquots of the supernatant were mixed
withsample loadingbuffer (125 mMTrispH 6.8, 20%glycerol, 10%
mercaptoethanol, 4% SDS, 0.05 % [w/v] bromphenol blue) and
incubated for 10 min at 99uC. After addition of phenylmethylsulfonyl
fluoride (PMSF) to a final concentration of 2.5 mM 10 ml aliquots of
the samples were subjected to SDS-PAGE and Western blotting for
the detection of PK-resistant prion protein.
SDS-PAGE and Western blotting
SDS-PAGE and Western blotting using the monoclonal anti-
PrP antibody 3F4 [45] for the detection of PrP were performed as
described elsewhere [28]. Marker proteins of 30- and 20 kDa
(Pharmacia, Germany) were used to specify the molecular mass of
blotted PrP. PK-digested homogenate from 263K scrapie hamster
brains used as an internal PrPres reference standard in Western
blot analyses was prepared, from different donor animals, as
outlined previously [28,46].
Densitometric Western blot analysis
Western blots were scanned in transmission mode and
electronically stored as bitmap (BMP) files. Densitometry was
performed using the open source software Image J (http://rsbweb.
nih.gov/ij/). For densitometric measurements the image type was
set to ‘‘8-bit’’ and blot pictures were inverted. Rectangles were
used to circumscribe the Western blot signals for monomeric un-,
mono- and diglycosylated PrPres in individual Western blot lanes
within one frame, and integrated signal densities were recorded.
Unspecific backgound staining on the blot membrane was
collected for similarly large areas and subtracted from the
corresponding PrPres measurements. Relative intensities of PrPres
signals were calculated as a percentage of the signal intensities of
PrPres reference standards (i. e. the integrated signal densities of
samples were divided by the integrated signal densities of PrPres
reference samples on the same Western blot after correction for
the background).
Relative intensities of PrPres signals after 1, 2, 3 or 4 rounds of
PMCA were plotted, using the software SigmaPlot 11.0 (Systat
Software, Germany), for PMCA samples seeded by i) different
amounts of homogenized 263K scrapie brain tissue, ii) reference
steel wires contaminated with 10
21-, 10
22-, 10
23-, 10
24-, 10
25-,
10
26-, 10
27- and 10
28-diluted SBH, or iii) test steel wires exposed
to different formulations/procedures for disinfection after con-
tamination with 10
21-diluted SBH. Upper parts of symmetrical
error bars were reproduced in plots in order to indicate the
variation (i. e. the range) of results for duplicate reference samples
and individual test samples after three independently performed
densitometric measurements of Western blot signals.
Residual seeding activities on test wires (SATW) were quantita-
tively assessed based on a systematic comparison of the levels of
PrPres amplification measured for individual batches of test wires
and duplicate batches of reference wires after PMCA. Maximum-,
mean- and minimum values of the seeding activity of test wires
(SATW[Max.],S A TW[Mean],S A TW[Min.]) were assessed for 1, 2, 3 and
4 rounds of PMCA by comparing the upper range, the mean, and
the lower range of measured PrPres staining seeded by test wires to
the lower range, the mean, and the upper range of measured
PrPres staining seeded by reference wires, respectively. The
scrapie seeding activities of reference wires contaminated with
10
21-, 10
22-, 10
23-, 10
24-, 10
25-, 10
26-, 10
27- and 10
28-diluted
SBH were referred to as SARW(10
21), SARW(10
22), SARW(10
23),
SARW(10
24), SARW(10
25), SARW(10
26), SARW(10
27) and
SARW(10
28).
Furthermore, we observed the following specific criteria in our
densitometric analyses: i) Test and reference samples showing
relative staining intensities that did not differ for more than 10
percentage points were considered as approximately equal, since
the overall variation found for reference samples in our study was
565 (mean 6 SD) percentage points (not shown). ii) When the
relative intensities of those reference samples that were in the
saturation region of Western blot staining did not exceed the
relative staining intensities of test samples for at least 10 percentage
points, they were not used for an assessment. iii) If no signal could
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finding was used for an assessment of the lowest reference seeding
activity larger than that of the test wires, only (provided that the
relative intensity of a relevant reference signal was at least 10%).
Finally, consolidated values of the residual seeding activities on
test wires (SATW[Cons.]) were deduced from the individual
assessments of SATW[Max.],S A TW[Mean] and SATW[Min.] for 1, 2,
3 and 4 rounds of PMCA.
Assessment and bioassay validation of prion infectivity
on test wires of the carrier assay for disinfection
The levels of infectivity present on reference wires, negative
control wires and on test wires exposed to formulations/
procedures (a), (b), (d), (e), (f), (g), (h), (i), (j) or (o) had been
determined previously [22,29], while the infectivity levels remain-
ing attached to test wires processed as decribed above for
formulations (c), (k), (l) or (m) were determined in this study by
bioassay in hamsters as described elsewhere using a dose-response
relationship established by end-point-titration [29].
The known infectivity titres of steel wires identical to those used
as reference wires in the seeding activity assay of this study were
applied as conversion factors for a tentative translation of the
seeding activities detected on test wires into titre estimates of
biological prion infectivity. These titre estimates were then
validated by comparison to the actual infectivity levels on the test
wires found in hamster bioassays.
Glial cell culture assay for scrapie seeding activity
Preparation of glial cell cultures from hamsters. Primary
glial cell cultures were prepared based on the protocol by Limaet al.
[47] with modifications: Neonatal Syrian hamsters were sacrificed
2–3 days after birth by decapitation. Brains were dissected and
stored in ice cold PBS/glucose (1000 mg/l D-glucose, 100 U/
ml penicillin, 100 mg/ml streptomycin and 0.5 mg/ml partricin)
until further processing. The cerebellum and meninges were
removed, and the remaining tissue was minced using a sterile
razor blade. The minced tissue was washed in PBS/glucose and
centrifuged for 3 min and 1000 rpm (Heraeus Varifuge 3.0) at
ambient temperature. The supernatant was discarded, and the
pellet was washed again in PBS/glucose prior to a second
centrifugation as described. The pellet was resuspended in 5 ml
Dulbecco’s modified Eagle medium [DMEM] containing 10%
[v/v] fetal calf serum [FCS], 1000 mg/l D-glucose, 3 mM
sodiumbicarbonate, 2 mM L-glutamine, 100 U/ml penicillin,
100 mg/ml streptomycin and 0.5 mg/ml partricin, and dispersed
by gentle trituration. A cell strainer (pore size: 40 mm, Becton
Dickinson) was used for the effective separation of cells and the
preparation of a homogeneous single-cell-suspension. The cell
suspension was centrifuged (5 min at 1200 rpm, ambient
temperature, Heraeus Varifuge 3.0) and resuspended in 10 ml
growth medium (GM: DMEM containing 10% [v/v] FCS,
1000 mg/l D-glucose, 2 mM L-glutamine, 100 U/ml penicillin,
100 mg/ml streptomycin, 0.5 mg/ml partricin]. The cell density
was determined by vital staining with trypan blue. 3610
6 cells
were grown in 25 ml GM using plastic cell culture flasks
(175 cm
2, NUNC) that had been pre-coated with poly-L-lysin
(1 mg/ml). Cultures were incubated at 37uCi nah u m i d i f i e d5 %
CO2–95% air atmosphere. Cell debris were removed by
washing with PBS, GM (25 ml) was renewed, and cells were
cultivated for a further seven days. Subsequently, for passage,
cultures were washed with PBS and incubated with 0.05%
trypsin in PBS until cells were completely detached from the
flask and separated from each other (Note: Enzymatic
detachment and separation of cells are of crucial importance
for the susceptibility to PrP seeding). Cells were centrifuged
(5 min at 1200 rpm, ambient temperature, Heraeus Variofuge
3.0), resuspended in GM and strained (cell strainer: pore size
40 mm). The cell density was determined by vital staining with
trypan blue, and 1,25610
5 cells were cultured for two days in
12.5 ml GM using plastic cell culture flasks (75 cm
2,N U N C )
t h a th a db e e np r e - c o a t e dw i t hp o l y - L - l y s i n( 1m g / m l ) .C u l t u r e s
were incubated at 37uC as described above.
Infection and harvesting of glial cell cultures. Glial cell
cultures adjusted to a cell density 1,25610
5 per flask were exposed
to i) 10
21-diluted NBH containing 0 g, 2.5610
25 go r
1.0610
26 g of 263K scrapie brain tissue per challenged culture,
or ii) to concentrated PMCA products seeded by negative control
wires (coated with 10
21-diluted NBH), reference wires
(contaminated with 10
28-diluted SBH), or test wires
(contaminated with 10
21-diluted SBH) that had been treated for
disinfection by formulations/procedures (a), (c) or (j). 80 mlo f
harvested PMCA products were centrifuged at 45.000 rpm and
4uC for 2.5 h in an Optima-max-ultracentrifuge (Beckman) using
a TLA-45 rotor, and the pellet was resuspended in 150 ml PBS.
10 ml of the suspensions containing the inocula according to i) or ii)
were added to cell cultures in 12.5 ml GM. After three days of
cultivation as described above the inoculum was removed, and the
cells were washed once with PBS.
Immediately after removal of the inoculum and washing of the
cells (i.e. at 3 days post initial exposure [DPE]) baseline cultures
were harvested, while in the other cultures the culture medium was
renewed and subsequently changed once a week until harvesting
of cells at 20, 31, 40 or 60 DPE. Cells were harvested by lysis in
800 ml 1% (w/v) sarcosyl and mechanical detachment using a cell
scraper. The resulting cell solutions were collected and centrifuged
at 45.000 rpm and 4uC for 2.5 h in an Optima-max-ultracentri-
fuge (Beckman) using a TLA-45 rotor. The resulting pellets were
resuspended in 100 ml PBS.
Analysis of glial cell cultures for PrP
C expression and
PrPres accumulation. For the testing of PrP
C expression
5 ml of resuspended pellets from cell cultures that had been
exposed to 10
21-diluted NBH and harvested at 40 DPE were
incubated with 45 ml of sample loading buffer for 10 min at
99uC, and 10 ml aliquots were subjected to SDS-PAGE and PrP-
Western blotting.
For the detection of PrPres accumulation 50 ml of resuspended
cell culture pellets (see above) were mixed with 5 ml 13% (w/v)
sarcosyl and 10 ml of Proteinase K stock solution (1 mg PK/ml;
final concentration of PK in digest samples: 150 mg/ml) and
incubated for 1 h at 37uC. Subsequently samples were mixed with
an equal volume of sample loading buffer and incubated for
10 min at 99uC. After addition of phenylmethylsulfonyl fluoride
(PMSF) to a final concentration of 2.5 mM 10 ml aliquots of the
samples were subjected to SDS-PAGE and Western blotting for
the detection of PK-resistant prion protein.
Analysis of glial cell cultures for propagation of seeding
activity. 5 ml aliquots of undiluted cell extracts harvested at 3
DPE and 40 DPE after challenge of cultures with 10
26 g of scrapie
brain tissue, NBH, or a PMCA product that had been seeded by
test wires treated for disinfection with formulation (a) were
subjected to PMCA for the detection of seeding activity. In a
similar experiment with cultures harvested after challenge with a
PMCA product that had been derived from test wires treated for
disinfection with formulation (c) 5 ml of a 1:25-diluted cell extract
were used for PMCA seeding. Detection of PrPres in 30 ml aliquots
from PMCA-batches obtained after 1, 2 or 3 rounds of PMCA by
SDS-PAGE and Western blotting was performed as described
above.
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Figure S1 Expression of PrP
C in glial cell cultures.
Western blot detection of PrP
C in a glial cell culture harvested at
40 days post initial exposure to 10
-1-diluted NBH. Lanes 1, 2 and 3
represent 1.0, 0.1 and 0.01 ml-aliquots from resuspended cell
culture pellets, respectively. Lane M, molecular mass marker (30
kDa).
(TIF)
Table S1 Hamster bioassay with test wires subjected to
different formulations for disinfection.
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Table S2 Residual infectivity and titre reductions on
test wires subjected to different formulations for
disinfection.
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